Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Department of Justice
Federal Trade Commission
Farmers Insurance
Medtronic
Colorcon

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 10,039,779

« Back to Dashboard

Which drugs does patent 10,039,779 protect, and when does it expire?

Patent 10,039,779 protects HARVONI and is included in one NDA.

This patent has thirty-six patent family members in twenty-one countries.

Summary for Patent: 10,039,779
Title:Combination formulation of two antiviral compounds
Abstract: Disclosed are pharmaceutical compositions having an effective amount of substantially amorphous ledipasvir and an effective amount of substantially crystalline sofosbuvir.
Inventor(s): Chal; Ben (Millbrae, CA), Mogalian; Erik (San Francisco, CA), Oliyai; Reza (Burlingame, CA), Pakdaman; Rowchanak (San Carlos, CA), Stefanidis; Dimitrios (Mountain View, CA), Zia; Vahid (San Carlos, CA)
Assignee: Gilead Pharmasset LLC (Foster City, CA)
Application Number:15/393,847
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 10,039,779
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 10,039,779

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Gilead Sciences Inc HARVONI ledipasvir; sofosbuvir TABLET;ORAL 205834-001 Oct 10, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y FOR TREATMENT-NAIVE GENOTYPE 1 PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION FOR A DURATION OF 8-WEEKS ➤ Sign Up
Gilead Sciences Inc HARVONI ledipasvir; sofosbuvir TABLET;ORAL 205834-001 Oct 10, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y FOR THE TREATMENT OF GENOTYPE 1, 4, 5 OR 6 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Johnson and Johnson
Argus Health
Deloitte
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.